Cargando…

Integration of point-of-care screening for type 2 diabetes mellitus and hypertension into the COVID-19 vaccine programme in Johannesburg, South Africa

BACKGROUND: South Africa grapples with a substantial burden of non-communicable diseases (NCDs), particularly type 2 diabetes (diabetes) and hypertension. However, these conditions are often underdiagnosed and poorly managed, further exacerbated by the strained primary healthcare (PHC) system and th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brennan, Alana T, Vetter, Beatrice, Masuku, Sithabiso D, Mtshazo, Bukelwa, Mashabane, Nkuli, Sokhela, Simiso, Venter, Willem DF, Kao, Kekeletso, Meyer-Rath, Gesine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662646/ https://www.ncbi.nlm.nih.gov/pubmed/37986070 http://dx.doi.org/10.1186/s12889-023-17190-6

Ejemplares similares

The cost of adding rapid screening for diabetes, hypertension, and COVID-19 to COVID-19 vaccination queues in Johannesburg, South Africa
por: Masuku, Sithabiso D., et al.
Publicado: (2023)

Integration of point-of-care screening for type 2 diabetes mellitus and hypertension with COVID-19 rapid antigen screening in Johannesburg, South Africa
por: Brennan, Alana T., et al.
Publicado: (2023)

The costs of interventions for type 2 diabetes mellitus, hypertension and cardiovascular disease in South Africa – a systematic literature review
por: Masuku, Sithabiso D., et al.
Publicado: (2022)

Impact of rilpivirine cross-resistance on long-acting cabotegravir-rilpivirine in low and middle-income countries
por: Steegen, Kim, et al.
Publicado: (2023)

Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial
por: Venter, Willem D. F., et al.
Publicado: (2017)

Profile of presentation of HIV-positive patients to an emergency department in Johannesburg, South Africa
por: Laher, Abdullah E., et al.
Publicado: (2021)

Change in body weight and risk of hypertension after switching from efavirenz to dolutegravir in adults living with HIV: evidence from routine care in Johannesburg, South Africa
por: Brennan, Alana T., et al.
Publicado: (2023)

Comparing Prospective Incident Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates During Successive Waves of Delta and Omicron in Johannesburg, South Africa
por: Sokhela, Simiso, et al.
Publicado: (2022)

Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans
por: Mateza, Somila, et al.
Publicado: (2023)

Challenges of teaching the deaf-blind learner in an education setting in Johannesburg: Experiences of educators and assistant educators
por: Manga, Tejal, et al.
Publicado: (2020)

Phase 3 trials of new antiretrovirals are not representative of the global HIV epidemic
por: Pepperrell, Toby, et al.
Publicado: (2020)

CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz
por: Griesel, Rulan, et al.
Publicado: (2020)

Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
por: Kawuma, Aida N., et al.
Publicado: (2023)

The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2014)

Sexual and reproductive health outcomes among female sex workers in Johannesburg and Pretoria, South Africa: Recommendations for public health programmes
por: Slabbert, Mariette, et al.
Publicado: (2017)

Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV
por: Mondleki, Enkosi, et al.
Publicado: (2022)

Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection
por: Sokhela, Simiso, et al.
Publicado: (2022)

‘The world is not only for hearing people – It’s for all people’: The experiences of women who are deaf or hard of hearing in accessing healthcare services in Johannesburg, South Africa
por: Masuku, Khetsiwe P., et al.
Publicado: (2021)

When donor funding leaves: an interrupted time-series analysis of the impact of integrating direct HIV care and treatment into public health services in a region of Johannesburg
por: Lince-Deroche, Naomi, et al.
Publicado: (2019)

Is there a role for doravirine in African HIV treatment programmes? A large observational resistance study in South Africa
por: Steegen, Kim, et al.
Publicado: (2021)

Usability assessment of seven HIV self-test devices conducted with lay-users in Johannesburg, South Africa
por: Majam, Mohammed, et al.
Publicado: (2020)

Concentration-Response Relationships of Dolutegravir and Efavirenz with Weight Change After Starting Antiretroviral Therapy
por: Griesel, Rulan, et al.
Publicado: (2022)

Increases in regimen durability associated with the introduction of tenofovir at a large public-sector clinic in Johannesburg, South Africa
por: Brennan, Alana T, et al.
Publicado: (2013)

Children's Hospital for Johannesburg
Publicado: (1920)

Walking the Hospital in Johannesburg
Publicado: (1919)

Treatment outcomes of HIV-positive patients on first-line antiretroviral therapy in private versus public HIV clinics in Johannesburg, South Africa
por: Moyo, Faith, et al.
Publicado: (2016)

Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa
por: Larson, Bruce A, et al.
Publicado: (2010)

Acute organophosphorus toxicity in a regional hospital in Johannesburg, South Africa: A retrospective chart review
por: Khonje, Vanessa, et al.
Publicado: (2023)

Costs and cost-effectiveness of treatment setting for children with wasting, oedema and growth failure/faltering: A systematic review
por: Mdege, Noreen Dadirai, et al.
Publicado: (2023)

Johannesburg Hospital Board's Experiment
Publicado: (1920)

Implementation of an mHealth App to Promote Engagement During HIV Care and Viral Load Suppression in Johannesburg, South Africa (iThemba Life): Pilot Technical Feasibility and Acceptability Study
por: Lalla-Edward, Samanta Tresha, et al.
Publicado: (2022)

Who is seeking antiretroviral treatment for HIV now? Characteristics of patients presenting in Kenya and South Africa in 2017‐2018
por: Brennan, Alana T, et al.
Publicado: (2019)

Johannesburg festival overture Viola concerto ; Symphony no. 2 /
por: Walton, William, 1902-
Publicado: (1996)

Citizenship status and engagement in HIV care: an observational cohort study to assess the association between reporting a national ID number and retention in public-sector HIV care in Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2017)

Radiographic viewing conditions at Johannesburg Hospital
por: Nyathi, T, et al.
Publicado: (2008)

Implementation of a PMTCT programme in a high HIV prevalence setting in Johannesburg, South Africa: 2002–2015
por: Mnyani, Coceka N., et al.
Publicado: (2020)

Monitored Implementation of COVID-19 Rapid Antigen Screening at Taxi Ranks in Johannesburg, South Africa
por: Majam, Mohammed, et al.
Publicado: (2022)

Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial
por: Venter, Willem Daniel Francois, et al.
Publicado: (2019)

The Prevalence of Mycoplasma genitalium and Association With Human Immunodeficiency Virus Infection in Symptomatic Patients, Johannesburg, South Africa, 2007–2014
por: Mahlangu, Mahlape P., et al.
Publicado: (2019)

An overview of tenofovir and renal disease for the HIV-treating clinician
por: Venter, Willem D.F., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dqsnrc5jadj96vtu8qa1isjs0d